Previous Close | 24.00 |
Open | 24.40 |
Bid | 25.20 x N/A |
Ask | 25.60 x N/A |
Day's Range | 24.40 - 25.00 |
52 Week Range | 20.60 - 33.80 |
Volume | |
Avg. Volume | 5 |
Market Cap | N/A |
Beta (5Y Monthly) | N/A |
PE Ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings Date | Aug 15, 2022 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
PARSIPPANY, N.J., Jan. 25, 2023 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), one of the largest pure-play diabetes care companies in the world following its April 1, 2022, spinoff from Becton, Dickinson and Company (“BD”), today held a grand opening ceremony at its new global headquarters office at 300 Kimball Drive, Suite 300, in Parsippany, N.J. The site will be home to members of the leadership team, global support functions and the North America commercial organization. embe
PARSIPPANY, N.J., Jan. 24, 2023 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), one of the largest pure-play diabetes care companies in the world, will host a conference call to discuss its fiscal first quarter 2023 financial results, provide an operational update, and host a question and answer session, at 8:00 a.m. Eastern Time (ET) on Tuesday, February 14, 2023. Those who would like to participate may access the live webcast here, or access the teleconference here. The live webc
In this article, we will take a look at the 12 52-week low dividend stocks to consider. You can skip this part and go to 5 52-Week Low Dividend Stocks To Consider. Dividend investing came into limelight in 2022 after the stock market began to fall amid rising inflation, interest rate hikes, and an uncertain […]